Funded Tech Companies
Vicinitas Therapeutics
Vicinitas Therapeutics, based in San Francisco, raised money from GV, Droia Ventures and Berkeley Catalyst Fund.
Company Overview
Company Name
Vicinitas Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
442 Littlefield Ave
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
The vision of Vicinitas Therapeutics is to become the leading company developing next-generation medicines that impact patient lives. Our vision is to use our proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/28/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Dan Marquess
Co-Founder
Daniel Nomura
Company Investors
- GV
- Droia Ventures (George Golumbeski)
- Berkeley Catalyst Fund
- Deerfield Management Company (Cameron Wheeler)
- Andreessen Horowitz (Jorge Conde)
- The Mark Foundation for Cancer Research
Browse more funded tech companies:
Viceversa | Vicious Cycle Software
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs